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Differentiation of naive CD4+ T cells into T helper type
1 (Th1) effector cells requires both T cell receptor
(TCR) signaling and cytokines such as interleukin-
12 and interferon g (IFN-g). Here, we report that
a third cytokine signal, mediated by the Janus family
tyrosine kinase 3 (Jak3) and signal transducer and
activator of transcription 5 (STAT5) pathway, is also
required for Th1 cell differentiation. In the absence
of Jak3-dependent signals, naive CD4+ T cells prolif-
erate robustly but produce little IFN-g after Th1 cell
polarization in vitro. This defect is not due to reduced
activation of STAT1 or STAT4 or to impaired upregu-
lation of the transcription factor T-bet. Instead, we
find that T-bet binding to the Ifng promoter is greatly
diminished in the absence of Jak3-dependent sig-
nals, correlating with a decrease in Ifng promoter
accessibility and histone acetylation. These data in-
dicate that Jak3 regulates epigenetic modification
and chromatin remodeling of the Ifng locus during
Th1 cell differentiation.
INTRODUCTION
After antigen stimulation, naive CD4+ T cells differentiate into one
of several functional classes of effector cells; most frequent
among these effector subsets are T helper type 1 (Th1) and
Th2 cells (Murphy and Reiner, 2002). The distinct patterns of
cytokine production by activated Th1 and Th2 effector cells are
the consequence of differential gene transcription, a process
that is regulated at multiple steps (Ansel et al., 2003; Lee et al.,
2006). The first step involves changes in chromatin accessibility.
Subsequent to this, specific transcription factors access the
open loci, where they bind to regulatory regions and activate
gene transcription. Finally, binding of some transcription factors
to their cis-acting regulatory elements directs chromatin-remod-
eling activity, leading to heritable changes in inducible transcrip-
tional activity.
The signaling pathways that contribute to Th cell differentia-
tion have been well characterized (Ho and Glimcher, 2002; Lee
et al., 2006). When naive CD4+ T cells are initially stimulated, la-
tent transcription factors nonselectively stimulate low amountsof both interferon g (IFN-g) and interleukin-4 (IL-4) production
(Avni et al., 2002). In the presence of IL-12, Th1 cell differentiation
is efficiently inducedwhen IFN-g stimulates Janus family tyrosine
kinase 1 (Jak1) and Jak2-dependent IFN-g receptor (IFN-gR)
signaling, leading to the activation of signal transducer and acti-
vator of transcription 1 (STAT1) and thereby inducing expression
of the Th1 cell-specific transcription factor, T-bet (Afkarian et al.,
2002). T-bet upregulates expression of IFN-g, as well as the IL-
12 receptor b2-subunit (IL-12Rb2) (Afkarian et al., 2002; Mullen
et al., 2001). IL-12, acting via Jak2 and Tyk2 to activate STAT4,
is not required for initial Th1 cell differentiation; instead, IL-12
amplifies the Th1 cell response by augmenting the production
of IFN-g (Yoshimoto et al., 1998). IL-12 signals together with T-
bet also act to downregulate the lineage commitment and
cytokine expression of the alternative Th2 cell subset (Mullen
et al., 2001; Ouyang et al., 1998).
Epigenetic regulation of cytokine loci also plays an essential
role in Th cell differentiation (Lee et al., 2006). The first definite ev-
idence of chromatin changes occurring during Th cell differenti-
ation was reported by Rao and colleagues, who identified T cell
lineage-specific DNAase I hypersensitive sites near the Ifng gene
promoter and enhancer (Agarwal and Rao, 1998). These hyper-
sensitive sites denote regions where chromatin structure has
been altered, and they reflect the occupancy of these sequences
with specific DNA binding proteins. Others have confirmed the
importance of epigenetic changes in the regulation of Th1 and
Th2 cell cytokine gene transcription (Bird et al., 1998; Valapour
et al., 2002). The chromatin modification most often studied dur-
ing Th cell differentiation is histone acetylation (Lee et al., 2006).
Changes in histone acetylation at the cytokine loci have been
well documented during Th cell differentiation (Avni et al., 2002;
Chang and Aune, 2005; Fields et al., 2002; Schoenborn et al.,
2007). Interestingly, time-course analysis indicates that the initial
increase in histone acetylation at the regulatory regions of both
the Il4 and Ifng genes is elicited in response to T cell receptor
(TCR) signaling and is independent of the cytokine milieu (Avni
et al., 2002). However, in Th1 cell- or Th2 cell-polarizing condi-
tions, cytokine locus-specific histone acetylation patterns are
observed by day 5 after activation and are maintained in the dif-
ferentiated effector cells (Avni et al., 2002; Fields et al., 2002;
Morinobu et al., 2004).
STAT4, the transcription factor activated by IL-12 signaling,
has been implicated in maintaining histone acetylation at the
Ifng locus in Th1 cells (Chang and Aune, 2005). The Th1 cell-
specific transcription factor, T-bet, also promotes histoneImmunity 28, 763–773, June 2008 ª2008 Elsevier Inc. 763
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DNase I hypersensitivity and histone hyperacetylation at the
Ifng locus in stimulated STAT4-deficient T cells (Fields et al.,
2002; Mullen et al., 2001). However, the early events that contrib-
ute to Ifng locus epigenetic modification in Th1 cells are still not
completely elucidated.
The Jak1-STAT1 and Jak2-STAT4 signaling pathways are
known to be important for Th cell differentiation. In contrast,
a third Jak kinase, Jak3, has not previously been implicated in
Th1 cell differentiation. Jak3 is required for signaling via the re-
ceptors for IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21, all of which
share a common receptor subunit, gc. These Jak3-dependent
cytokines primarily activate STAT5 and are critical for lymphoid
generation, maturation, homeostasis, and survival (Imada and
Leonard, 2000). Although it is not surprising that Jak3 is essential
for Th2 differentiation, because of its essential role in IL-4 signal-
ing, little is known about the role of Jak3-dependent cytokine sig-
nals in Th1 differentiation. In this study, we examined this issue
by assessing Th1 differentiation and IFN-g production by naive
CD4+ T cells from Jak3-deficient and STAT5-deficient mice.
We complemented these studies with analysis of wild-type
CD4+ T cells treatedwith a pharmacological inhibitor of Jak3. To-
gether, these experiments demonstrated that Jak3- and STAT5-
dependent cytokine signals regulate Th1 cell differentiation by
controlling chromatin remodeling at the Ifng locus.
RESULTS
IFN-g Production by Th1 Cells Is Greatly Reduced
in the Absence of Jak3
To investigate the potential role of Jak3-dependent cytokine
signals in Th1 cell differentiation, we established an in vitro assay
using homogenous populations of naive Jak3/ CD4+ T cells.
To accomplish this, we first crossed Jak3/ mice to the trans-
genic line expressing the OT-II TCR (Barnden et al., 1998). Be-
cause gc cytokines are required for naive CD4+ T cell survival
in vivo (Lantz et al., 2000), we also introduced a transgene
expressing Bcl-2 (Strasser et al., 1994). The resulting Jak3/
OTII-transgenic Bcl2-transgenic (hereafter referred to as Jak3/
OT-II Bcl2) mice have peripheral CD4+ T cells that predominantly
exhibit a naive (CD44lo) phenotype (Figure S1 available online).
However, to ensure a starting population of naive cells, we chose
to use CD4+CD8 single-positive (CD4 SP) thymocytes from
these mice for our experiments.
CD4 SP thymocytes were isolated from Jak3+/ or Jak3/
OT-II Bcl2 mice, labeled with carboxyfluorescein diacetate suc-
cinimidyl ester (CFSE), stimulated with anti-CD3 and anti-CD28,
and cultured under nonskewing or Th1 cell-skewing conditions
without addition of exogenous IL-2. After 4 days, cells were re-
stimulated, and IFN-g was examined by intracellular cytokine
staining. As shown in Figure 1A, in the absence of Jak3, the per-
centage of IFN-g-producing cells was reduced from an average
of 12.5% ± 2.7% to 0.5% ± 0.4% (p < 0.001) and 27.1% ± 4.1%
to 7.0% ± 6.8% (p < 0.01) under nonskewing and Th1 cell-skew-
ing conditions, respectively. In addition, the percentage of lym-
photoxin a-producing cells was also decreased in the absence
of Jak3 (data not shown). Cell division, as assessed by CFSE
dilution, was similar between Jak3+/ and Jak3/ OT-II Bcl2
cells (Figure 1A), indicating that the reduced Th1 cell cytokine764 Immunity 28, 763–773, June 2008 ª2008 Elsevier Inc.production in the Jak3-deficient T cells was not due to impaired
proliferation.
To confirm these findings, we examined cytokine secretion by
Jak3/ and Jak3+/ OT-II Bcl2 T cells after stimulation in Th1
cell- and Th2 cell-polarizing conditions. As shown in Figure 1B,
under Th1 cell-skewing conditions, Jak3/ CD4 SP cells did
not secrete Th2 cell cytokines (IL-4, IL-5, and IL-10) and pro-
duced much less IFN-g than Jak3+/ cells. As expected on the
basis of the role for IL-4 receptor signaling during Th2 cell differ-
entiation (Murphy and Reiner, 2002), Jak3/ CD4 SP cells stim-
ulated under Th2 cell-polarizing conditions did not produce
detectable amounts of IL-4, IL-5, or IL-10 (Figure 1B).
To determine whether the impaired production of IFN-g by
Jak3/ CD4 SP cells resulted from reduced expression of Ifng
messenger RNA (mRNA), we performed real-time quantitative
reverse transcriptase-polymerase chain reaction (RT-PCR).
Consistent with the protein data, Ifng transcript expression
was reduced in Jak3/CD4 SP cells compared to Jak3+/ cells,
after culture under both nonskewing and Th1 cell-skewing con-
ditions (Figure 1C). Together, these data indicate that Jak3-
dependent signals are required for optimal production of IFN-g
in differentiated CD4+ T cells and suggest that these signals
promote maximal transcription of the Ifng gene.
Transcription Factors Important for Th1 Cell
Differentiation Are Independent of Jak3
Our previous studies indicated that T cells from Jak3-deficient
mice have intact TCR signaling (Thomis et al., 1997). For the ex-
amination of whether IFN-g-STAT1 and IL-12-STAT4 pathways
are intact in the absence of Jak3, freshly isolated CD4 SP thymo-
cytes from Jak3+/ and Jak3/OT-II Bcl2 mice were stimulated
with IFN-g and assessed for STAT1 tyrosine phosphorylation
(Figure 2A); further, differentiated Jak3+/ and Jak3/ Th1 cells
were assessed for STAT4 phosphorylation in response to IL-12
stimulation (Figure 2B). As shown, both of these responses
were intact in the absence of Jak3. We also examined upregula-
tion of T-bet, a master transcription factor for Th1 differentiation
which is induced by IFN-g signaling in T cells (Mullen et al.,
2001; Szabo et al., 2000). Although no T-bet was detected in
naive T cells, Jak3+/ CD4 SP cells upregulated T-bet mRNA
andprotein after stimulation in both nonskewing and Th1 cell-po-
larizing conditions (Figure 2C, and data not shown). Jak3/ cells
failed to induce T-bet under nonskewing conditions, perhaps as
a result of their failure to produce any IFN-g after activation. In
contrast, Jak3/ cells cultured under Th1 cell-skewing con-
ditions expressed comparable amounts of T-bet mRNA and
protein compared to the Jak3+/ control cells (Figure 2C). To-
gether with our previous studies, these data indicate that three
important pathways for Th1 cell differentiation, TCR signaling,
IFN-g-STAT1, and IL-12-STAT4, are intact in the absence of
Jak3-dependent cytokine signals.
Pharmacological Inhibition of Jak3 Leads to Impaired
IFN-g Production during Th1 Differentiation
To rule out the possibility that Jak3/ T cells are developmen-
tally abnormal, leading to their impaired Th1 cell differentiation,
we examined cytokine production by Jak3+/+ CD4+ T cells
treated with a pharmacological Jak3 inhibitor. Compound
PS078507 was developed by Pharmacopeia (Princeton, NJ)
Immunity
Jak3 Signals Induce Ifng Epigenetic RegulationFigure 1. Differentiation of CD4+ T Cells
Leads to Impaired IFN-g Production in the
Absence of Jak3
CFSE-labeled CD4SP thymocytes from Jak3+/
and Jak3/ OT-II Bcl2 mice were stimulated
with anti-CD3 plus anti-CD28 and cultured under
non-, Th1 cell-, or Th2 cell-skewing conditions
for 4 days.
(A) Cells were restimulated with PMA plus ionomy-
cin for 5 hr. Dot plots show intracellular staining for
IFN-g versus CFSE fluorescence. The graphs
show percentages of IFN-g-producing cells from
five different experiments, with the means indi-
cated by horizontal bars. Differences between
Jak3+/ and Jak3/ responses are statistically
significant, with the p values indicated.
(B and C) After 4 day culture in Th1 cell- or Th2
cell-polarizing conditions, cells were restimulated
with PMA and ionomycin for 24 hr. Supernatants
were analyzed for production of IFN-g, IL-4, IL-5,
and IL-10 by ELISA (B). Error bars indicate the
standard deviation (SD) of values obtained from
stimulations performed in triplicate. Ifng mRNA
expression was analyzed by real-time quantitative
PCR (C). Data are normalized to amounts of
18srRNA in each sample. Error bars indicate the
SD of transcript values obtained from triplicate
reactions.and had an IC50 of 2.1 nM for inhibition of Jak3 enzyme activity
(Figure S2A). Inhibitory activity (IC50) on the other Jak kinases
was measured at 20 nM, 6.3 nM, and 12 nM for Jak2, Jak1,
and Tyk2, respectively, and was more than 300 nM on a panel
of 30 additional kinases tested (data not shown). In a cellular as-
say examining inhibition of IL-2-induced proliferation of human
peripheral blood T cells, the IC50 was 73 nM (Figure S2B). To de-
termine the optimal concentration of PS078507 for Jak3 inhibi-
tion inmurine peripheral CD4+ T cells, we assessed IL-2-induced
STAT5 phosphorylation after treatment with varying concentra-
tions of PS078507 (Figure S2C). PS078507 completely inhibited
IL-2-induced STAT5 phosphorylation in Jak3+/+ CD4+ T cells at
625 nM. We also found that PS078507 had no effect on T cell
proliferation induced by TCR stimulation over the course of a 4
day assay (Figure 3A). Furthermore, PS078507 had no inhibitory
effect on TCR signaling, as assessed by CD69 upregulation after
TCR stimulation of naive Jak3+/+ CD4+ T cells (Figure S2D).
We then tested PS078507 for its effect on Th1 cell differentia-
tion leading to IFN-g production. As shown in Figures 3B and 3C,
inhibition of Jak3 enzymatic activity in Jak3+/+ OT-II transgenic
CD4+ T cells greatly diminished the percentage of IFN-g-secret-
ing cells from an average of 19.7% ± 7.3% to 1.9% ± 1.3% (p <
0.01) under nonskewing conditions and 42.7% ± 8.9% to 19.5% ±
7.0% (p < 0.01) under Th1 cell-skewing conditions. As seen with
Jak3/ T cells, T-bet expression was greatly reduced in CD4+ T
cells cultured under nonskewing conditions in the presence of
PS078507; however, Jak3+/+ T cells stimulated under Th1 cell-
polarizing conditions showed normal upregulation of T-bet,even in the presence of the Jak3 inhibitor (Figure 3D). These find-
ings confirmed the results seen with Jak3/ CD4 SP cells. To-
gether, these data indicate that the impaired production of
IFN-g in Th1 cells differentiating in the absence of Jak3-depen-
dent signals cannot be explained by defects in the known tran-
scription factors required for Ifng gene expression.
In Vivo Binding of T-bet to the Ifng Promoter Is Impaired
in the Absence of Jak3 Signals
The Ifng gene is a direct target of the transcription factor, T-bet
(Lovett-Racke et al., 2004). Because T-bet protein expression
was not reduced in the absence of Jak3-dependent signals,
we considered the possibility that Jak3-dependent signaling
might regulate the ability of T-bet to interact with its responsive
element in the Ifng promoter. To address this, chromatin immu-
noprecipitation (ChIP) assays were performed to assess the
in vivo binding of T-bet to the Ifng proximal promoter in Jak3+/
versus Jak3/ OT-II Bcl2 cells (Figure S4; primer set #1).
CD4 SP thymocytes were activated and cultured under Th1
cell-skewing conditions for 4 days. As shown in Figure 4A, naive
CD4 SP thymocytes from Jak3+/ or Jak3/OT-II Bcl2mice had
no detectable T-bet bound to the Ifng promoter (lane 3 and lane
6). After Th1 cell differentiation, T-bet bound to the Ifng promoter
was easily detectable in Jak3+/ T cells but substantially dimin-
ished in Jak3/ T cells (lane 9 and lane 12). We confirmed these
findings with Jak3+/+ CD4+ T cells stimulated in Th1 cell-skewing
conditions in the presence of the Jak3 inhibitor PS078507 (Fig-
ure 4B). Overall, these data correlated with the pattern of IFN-gImmunity 28, 763–773, June 2008 ª2008 Elsevier Inc. 765
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that reduced production of IFN-g under these conditions may re-
sult from an impaired ability of T-bet to bind to the Ifng promoter
and thereby to activate Ifng gene transcription.
The apparent inability of T-bet to promote transcription of
the Ifng gene is not due to a global defect in T-bet activity or func-
tion. Jak3+/ and Jak3/ OT-II Bcl2 CD4 SP thymocytes were
activated and stimulated under Th1 cell-polarizing conditions
for 4 days, and mRNA expression of the IL-12Rb2 chain, Hlx,
and Ets-1 genes was examined (Figure S3). Both populations
showed comparable expression of transcripts encoding the
IL-12Rb2 chain and Ets-1, whereas Jak3/ cells had reduced
expression of Hlx mRNA. Because IL-12Rb2 and Hlx are both
transcriptional targets of T-bet (Mullen et al., 2001; Mullen
et al., 2002), these findings indicate that T-bet is transcriptionally
competent to promote expression of IL-12Rb2 but selectively
loses the ability to mediate transcription of other genes, such
as Ifng and Hlx.
Figure 2. STAT1 Phosphorylation, STAT4 Phosphorylation, and
T-bet Expression Are Not Impaired in Jak3-Deficient Th1 Cells
(A) Freshly isolated purified CD4SP thymocytes from Jak3+/ and Jak3/ OT-II
Bcl2 mice were stimulated with or without IFN-g (100 ng/ml) for 30 min. Total
cell lysates were prepared and blotted for STAT1p and total STAT1. CD4+
splenocytes from Jak3+/+ OTII-transgenic mice were used as a control.
(B) Purified CD4SP thymocytes from Jak3+/ and Jak3/OT-II Bcl2micewere
cultured in Th1 cell-skewing conditions for 4 days. Cells were rested overnight
and then stimulated with or without IL-12 (15 ng/ml) for 25 min. Total cell
lysates were prepared and blotted for STAT4p and total STAT4.
(C) PurifiedCD4SP thymocytes from Jak3+/ and Jak3/OT-II Bcl2micewere
stimulated under non-, Th1 cell-, or Th2 cell-skewing conditions for 4 days. T-
bet mRNA amounts were analyzed by real-time quantitative PCR. Data are
normalized to the levels of 18srRNA in each sample (left panel). Total cell ly-
sates from freshly isolated CD4SP thymocytes (naive) or polarized Th1 cells
(Th1) were prepared and immunoblotted for T-bet and b-actin (right panel). Er-
ror bars indicate the SD of transcript values obtained from triplicate reactions.766 Immunity 28, 763–773, June 2008 ª2008 Elsevier Inc.Th1 Cells Differentiating in the Absence of Jak3
Signaling Show Reduced Ifng Promoter Accessibility
The results described above suggested that T-bet function in
Th1 cells may be regulated by chromatin structure. To examine
this issue further, we examined the accessibility of the Ifng prox-
imal promoter using restriction endonuclease digestion followed
by ligation-mediated PCR (LM-PCR; Figure S4, primer set #2).
As shown in Figure 5A, the Ifng promoter in naive Jak3+/ or
Jak3/ CD4 SP thymocytes was not accessible to endonucle-
ase digestion. After 4 days of stimulation under Th1 cell-polariz-
ing conditions, the Ifng promoter showed dramatically increased
accessibility in Jak3+/ SP cells. In contrast, the signal from the
Jak3/ SP cells was reduced to approximately 30% of that
seen in the control cells, indicating that the Ifng promoter is
markedly less accessible in Jak3-deficient T cells cultured under
Th1-skewing conditions.
By using the ChIP assay, we next examined the acetylation
status of histone H3 at the Ifng promoter in Th1 cells stimulated
in the presence or absence of functional Jak3 (Figure S4, primer
set 3). As shown in Figure 5B, naive Jak3+/ and Jak3/ OT-II
Bcl2 CD4 SP thymocytes had a low level of histone H3 acetyla-
tion at the Ifng promoter. After 4 days of culture in Th1 cell-skew-
ing conditions, Jak3+/ cells displayed strong hyperacetylation
of histone H3 at the Ifng promoter. In contrast, histone H3 acet-
ylation of the Ifng promoter was reduced in Jak3/ Th1 cells,
consistent with the diminished accessibility of this region to re-
striction endonuclease digestion. These findings were also con-
firmed with Jak3+/+ T cells stimulated under Th1 cell-polarizing
conditions in the presence of the Jak3 inhibitor, PS078507 (Fig-
ure 5C). Furthermore, all findings were confirmed with a second
set of PCR primers (Figure S4, primer set #4; data not shown).
Together, these data strongly suggest that Jak3-dependent
cytokine signals are required for chromatin remodeling of the
Ifng locus during Th1 cell differentiation.
To further assess the role of histone acetylation in Jak3-
dependent IFN-g production, we pharmacologically induced
histone acetylation of the Ifng promoter by using a histone de-
acetylase (HDAC) inhibitor, sodium butyrate. Addition of sodium
butyrate during Th1 cell differentiation of both Jak3+/ and
Jak3/ OT-II Bcl2 CD4 SP thymocytes resulted in increased
production of IFN-g compared to untreated cells (Figure 5D).
This finding was confirmed with Jak3+/+ CD4+ T cells stimulated
in the presence of the Jak3 inhibitor, PS078507 (data not shown).
Overall, the data presented here indicate that Jak3-dependent
cytokine signals induce IFN-g production via chromatin remod-
eling of the Ifng locus.
Jak3 Acts at 24–72 hr after Activation to Promote
Histone Acetylation at the Ifng Promoter
Our data indicate that Jak3-dependent signals promote IFN-g
production by inducing histone H3 acetylation. Examination of
the time course of histone H3 acetylation at the Ifng promoter
during Th1 cell differentiation by ChIP assay demonstrated
only a low basal amount of histone H3 acetylation in the first
24 hr after stimulation. Histone H3 acetylation increased at
48 hr and then increased further at 72 hr (Figure 6A). These
data indicate that during Th1 cell differentiation, selective Ifng
chromatin remodeling occurs rapidly between 24 and 72 hr after
activation.
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Jak3 during Th1 Cell Differentiation Leads
to Impaired IFN-g Production
(A) Purified CD4+ splenocytes from Jak3+/+ OTII-
transgenic mice were labeled with CFSE and stim-
ulated with anti-CD3 plus anti-CD28 for 4 days in
the presence of vehicle alone (WT vehicle) or
PS078507 at 625 nM (Jak3 inhibitor). Histograms
show CFSE fluorescence.
(B–D) CD4+ splenocytes from Jak3+/+ OTII-trans-
genic mice were cultured under non- and Th1
cell-skewing conditions for 4 days, in vehicle alone
or PS078507 (625 nM). Cells were restimulated
with PMA plus ionomycin for 6 hr. Dot-plots
show IFN-g intracellular staining versus forward
scatter (B). The graphs show percentages of
IFN-g-producing cells from four different experi-
ments, with the means indicated by horizontal
bars (C). Differences between cells cultured in
vehicle alone or PS078507 (Jak3 inhibitor) are
statistically significant, with the p values indicated.
Total cell lysates were prepared and immunoblot-
ted for T-bet and b-actin (D).Use of a small molecule Jak3 inhibitor allowed us to assess the
kinetic parameters of the Jak3-dependent signal and to correlate
these data to the changes in histone acetylation. For these
experiments, Jak3+/+ CD4+ T cells were stimulated under Th1-
polarizing conditions in the absence of inhibitor PS078507 or
with inhibitor added at varying times after the initial activation
of the T cells. At day 4, cells were restimulated and IFN-g pro-
duction was examined by intracellular cytokine staining. Consis-
tent with the histone H3 acetylation pattern, PS078507 inhibited
IFN-g production when cells were treated with the inhibitor
starting at 0 hr, 1 hr, 3 hr, 6 hr, 12 hr, and 24 hr after stimulation.
However, the inhibitory effect of PS078507 was substantially di-
minished when inhibitor was applied at 48 hr and was ineffective
when added at 72 hr after stimulation (Figure 6B). Similarly, acet-
ylation of histone H3 at the Ifng promoter was completely in-
hibited by PS078507 when added 24 hr after initial T cell activa-
tion but was ineffective when cells were stimulated under Th1
cell-polarizing conditions for 72 hr prior to addition of the Jak3 in-
hibitor (Figure 6C). These findings indicate that the predominant
action of Jak3-dependent signals in promoting optimal IFN-g
production occurs between 24 and 72 hr after stimulation and
that these signals regulate Ifng chromatin remodeling during
Th1 cell differentiation.
STAT5 and IL-2 Promote Optimal IFN-g Production
during Th1 Cell Differentiation
After Jak kinase activation, STAT5 translocates to the nucleus,
where it activates the transcription of target genes (Lin and Leo-
nard, 2000). In human natural killer (NK) cells, a STAT5 binding
site has been identified in a distal region of the IFNG gene, 3.6
kb upstream of the transcriptional start site. This STAT5 binding
site serves as a target for epigenetic modification of the IFNG lo-
cus or as an IL-2-induced transcriptional enhancer (Bream et al.,
2004; Gonsky et al., 2004). STAT5 also binds to this region of theIFNG gene in human T cells, where it enhances IFNG gene
expression after CD2 stimulation (Gonsky et al., 2004). In murine
T cells, STAT5 binding to the Ifng promoter has not previously
been examined. However, several Ifng regulatory elements
have been identified in these cells through DNase I hypersensi-
tive site (HS) mapping and conserved noncoding sequence
(CNS) searching. These elements are IfngCNS-34 (Hatton
et al., 2006), IfngCNS-22 (Hatton et al., 2006), IfngCNS-5.5
(Lee et al., 2004; Shnyreva et al., 2004), HS-0.3 (Agarwal and
Rao, 1998), and IfngCNS+18 (Shnyreva et al., 2004), which are
34 kb, 22 kb, 5.5 kb, 0.3 kb and +18 kb from the IFN-g
transcriptional initiation site, respectively. To investigate whether
STAT5 binds to any of these regulatory sites, we utilized the ChIP
assay (Figure S4, primer sets #5–10). As shown in Figure 7A, no
STAT5 binding was detected to IfngCNS-34 or IfngCNS-22 (Fig-
ure 7A, lanes 1 and 2). Furthermore, although STAT5 binds to the
3.6 kb region of the human IFNG gene, we could not detect
STAT5 binding to the corresponding region of the murine Ifng
locus (Figure 7A, lane 4). Interestingly, CD4+ T cells cultured in
Th1-polarizing conditions for 48 hr exhibited easily detectable
STAT5 binding to IfngCNS-5.5 and HS-0.3 after IL-2 stimulation
(Figure 7A, lanes 3 and 5). In addition, we found extremely weak
binding of STAT5 to IfngCNS+18 (Figure 7A, lane 6). These data
suggest that the Jak3-STAT5 pathway might directly regulate
Ifng gene expression.
To determine whether STAT5 is required during Th1 cell differ-
entiation for optimal IFN-g production, we utilized T cells from
conditional STAT5a and STAT5b double-deficient mice (Cui
et al., 2004). To accomplish this, we crossed mice carrying
a floxed Stat5 allele to CD2-Cre transgenic mice (de Boer
et al., 2003). CD4 SP thymocytes were isolated and stimulated
under Th1 cell-polarizing conditions. After 4 days, cells were re-
stimulated and IFN-g production was assessed by intracellular
cytokine staining. Consistent with the data from CD4 SP cellsImmunity 28, 763–773, June 2008 ª2008 Elsevier Inc. 767
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entiation of IFN-g-producing Th1 effector cells (Figure 7B). Fur-
thermore, addition of sodium butyrate during the differentiation
process promoted greatly enhanced production of IFN-g in T
cells lacking STAT5 (Figure 7B).
To determine whether IL-2 is the cytokine responsible for
activating Jak3 and STAT5 during Th1 cell differentiation and
thereby promoting IFN-g production, we stimulated wild-type
(Jak3+/+ Stat5ab+/+) T cells under Th1 cell-polarizing conditions
in the presence of anti-IL-2 and anti-IL2 receptor. As shown in
Figure 7C, inhibition of IL-2 signaling was nearly as effective at
preventing the differentiation of IFN-g-producing Th1 cells as
was the Jak3 inhibitor, PS078507. We also tested whether addi-
tion of exogenous IL-7 could replace IL-2 and promote optimal
IFN-g production. As shown in Figure 7C, IL-7 was onlymodestly
effective at promoting IFN-g production. The relative activities of
IL-2 and IL-7 at inducing IFN-g production during Th1 cell differ-
entiation correlated well with their ability to induce STAT5
tyrosine phosphorylation in differentiating Th1 cells (Figure 7D).
These data provide further evidence consistent with a role
for STAT5 in promoting IFN-g production during Th1 cell
differentiation.
DISCUSSION
Th1 versus Th2 cell fate determination and maintenance are
regulated by exogenous signals through the TCR and cytokine
receptors, which together activate distinct transcription factor
networks and promote epigenetic modifications of lineage-
specific cytokine loci (Ansel et al., 2003). Here, we show that
CD4+ T cells require Jak3-dependent signals to produce optimal
Figure 4. In Vivo Binding of T-bet to the Ifng Promoter Is Impaired in
Jak3-Deficient Cells
(A) PurifiedCD4SP thymocytes from Jak3+/ and Jak3/OT-II Bcl2mice were
cultured under Th1 cell-skewing conditions for 4 days (lanes 7–12) and com-
pared with freshly isolated cells (naive, lanes 1–6). ChIP analysis was done
with an anti-T-bet (lanes 3, 6, 9, and 12) or a rabbit immunoglobulin G (IgG)
control antibody (lanes 2, 5, 8, and 11).
(B) CD4+ splenocytes from Jak3+/+ OTII-transgenic mice were cultured with
vehicle alone or PS078507 (625 nM) under Th1 cell-skewing conditions for
4 days. ChIP analysis was done with a rabbit IgG antibody control (top) or
an anti-T-bet (middle). The location of PCR primers is indicated in Figure S4.768 Immunity 28, 763–773, June 2008 ª2008 Elsevier Inc.amounts of IFN-g during Th1 cell differentiation, independently
of effects on cell division. Jak3 activity is not required for TCR
signaling or for the IFN-g-STAT1-T-bet and IL-12-STAT4 path-
ways. Instead, Jak3-dependent signals regulate chromatin
remodeling at the Ifng locus, promote histone H3 acetylation,
and control the accessibility of T-bet to the Ifng promoter to
induce optimal IFN-g production by Th1 cells.
Helper T cell differentiation is coupled to cell-cycle progres-
sion. As seen first by Bird and colleagues, IFN-g is expressed
by an increasing frequency of cells with each cell division (Bird
et al., 1998), a finding also illustrated in our data (Figure 1A). Al-
though gc-dependent cytokines have been shown to promote
lymphoid proliferation (Sugamura et al., 1995), we find that cells
lacking Jak3 (i.e., Jak3/) as well as Jak3+/+ cells treated with
a small molecule Jak3 inhibitor are able to proliferate compara-
bly to wild-type cells in the context of a 4 day in vitro assay.
Thus we conclude that Jak3-dependent signals are directly influ-
encing effector T cell differentiation rather than proliferation.
Our data indicate that a third cytokine signal, mediated by
Jak3 and STAT5, is required during the early stages of Th1 cell
differentiation (prior to 72 hr). We complemented our studies
on Jak3-deficient and STAT5-deficient T cells with experiments
on wild-type CD4+ T cells treated with a small molecule inhibitor
of Jak3 enzymatic activity, PS078507. In all cases, the inhibitor
data are completely concordant with the results obtained with
Jak3/ cells, demonstrating that the effects seen are not due
to abnormal development of, or compensatory changes in,
Jak3/ or Stat5ab/ cells. Further, the experiments utilizing
the Jak3 inhibitor indicate that Jak3 kinase activity is required
for its role in promoting Ifng chromatin remodeling.
One potential caveat of the inhibitor experiments is the fact
that PS078507 has significant inhibitory activity on Jak1, as
well as Jak3. Because Jak1 is a key component of IFN-g recep-
tor signaling (Muller et al., 1993) and IFN-g receptor signaling has
been implicated in the induction of T-bet expression and thus in
Th1 differentiation (Afkarian et al., 2002), inhibition of Jak1 activ-
ity by PS078507 could contribute to the impaired Th1 cell differ-
entiation seen in the presence of the inhibitor. However, several
lines of evidence indicate that this scenario is unlikely. First, we
detect normal amounts of T-bet in wild-type CD4+ T cells cul-
tured under Th1 cell-polarizing conditions in the presence of
PS078507. Second, we observe that IFN-g receptor is totally
absent from CD4+ T cells by 6 hr after initial activation, and fur-
ther, that IFN-g-induced STAT1 phosphorylation is also unde-
tectable by 3 hr after T cell activation (Bach et al., 1995; Van
De Wiele et al., 2004; and data not shown). Because we find
that PS078507 still inhibits optimal IFN-g production when
added to Th1 cell-polarizing cultures after 24 hr of activation, it
is extremely unlikely that its ability to block this response is
due to inhibition of IFN-g receptor signaling. Thus, the concor-
dance between our findings based on analysis of Jak3/ T cells
with the data using PS078507 provides strong support for a role
of Jak3 signaling in Th1 cell differentiation.
T-bet is considered the master regulator of Th1 cell lineage
commitment (Szabo et al., 2000). T-bet controls Th1 cell pro-
grams by promoting Ifng gene remodeling (Mullen et al., 2002);
in addition, T-bet acts to directly induce transcription of the Ifng
(Lovett-Racke et al., 2004), IL-12Rb2 (Mullen et al., 2001), and
Hlx (Mullen et al., 2002) genes. With regard to Ifng expression,
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Ifng Promoter Is Reduced in Th1 Cells Dif-
ferentiated in the Absence of Jak3-Depen-
dent Signals
(A andB) Purified CD4SP thymocytes from Jak3+/
and Jak3/ OT-II Bcl2 mice were stimulated un-
der Th1 cell-skewing conditions for 4 days (lanes
7–12). Freshly isolated cells (naive, lanes 1–6)
were used for comparison. Nuclei were isolated
and digested with HinfI, and 3-fold dilutions of
genomic DNA were subjected to LM-PCR with
primers for the Ifng proximal promoter (LM-PCR
primer set #2) (A). ChIP analysis was performed
with an antibody to acetylated histone H3 (lanes
3, 6, 9, and 12) or a rabbit IgG control antibody
(lanes 2, 5, 8, and 11) (H3 primer set #3) (B).
(C) CD4+ splenocytes from Jak3+/+ OTII-trans-
genic mice were cultured in vehicle alone or with
the Jak3 inhibitor (625nM) in Th1 cell-skewing
conditions for 4 days. ChIP analysis was per-
formed with a rabbit IgG control antibody (top) or
antibody to acetylated histone H3 (middle) (H3
primer set #3).
(D) Purified CD4SP thymocytes from Jak3+/ and
Jak3/ OT-II Bcl2 mice were stimulated under
Th1 cell-skewing conditions. Parallel cultures
were treated with or without sodium butyrate
(SB; 200 mM), added at 24 hr after stimulation. At
day 4, cells were restimulated with PMA and iono-
mycin. The graph shows the percentage of cells
producing IFN-g as assessed by intracellular
staining. Data are pooled from three independent
experiments. Differences between sodium buty-
rate treated and untreated samples for each geno-
type of cells are statistically significant, with p
values indicated. Differences between sodium
butyrate treated Jak3+/ and Jak3/ cells are
not significant. Error bars indicate the SD of per-
cent of IFN-g-producing cells obtained from three
independent experimentsboth of these functions require T-bet binding to the Ifng locus. In-
terestingly, our data indicate that T-bet protein expression alone
is not sufficient for maximal T-bet binding to the Ifng promoter.
These findings could be accounted for by two possible mecha-
nisms. First, it is formally possible that a potential posttransla-
tional modification of T-bet (Hwang et al., 2005) is impaired in
the absence of Jak3-dependent signals. Arguing against this
possibility, the expression of the IL-12Rb2 chain, one of the direct
transcriptional targets of T-bet (Mullen et al., 2001), is not im-
paired in Th1 cells lacking Jak3, indicating that the T-bet protein
present in these cells is transcriptionally active.
Instead, we favor the notion that impaired T-bet binding in vivo
to the Ifng gene is due to reduced accessibility of the Ifng locus in
the absence of Jak3-dependent signals. In previous studies, the
importance of T-bet and STAT4 in Ifng chromatin remodeling
was demonstrated with T-bet- or STAT4-deficient T cells or by
a retroviral overexpression system (Chang and Aune, 2005;
Fields et al., 2002; Mullen et al., 2001); therefore, it was not pos-
sible to determine precisely when these factors carry out their
functions. By using a pharmacological Jak3 inhibitor, we findthat Jak3-dependent signals function at 24–72 hr after initial T
cell activation. Because TCR signals act within 24 hr to regulate
Ifng epigenetic modification (Avni et al., 2002), these data sug-
gest that Jak3-dependent signals function after TCR signaling
to promote chromatin remodeling. The impaired ability of T-bet
to bind to the Ifng promoter in Jak3/ cells further suggests
that Jak3-dependent signals act prior to, or synergistically
with, T-bet to regulate Ifng gene expression. After 72 hr, this
Jak3-dependent signal is dispensable, and T-bet plus STAT4
is sufficient to reinforce and maintain the open status of the
Ifng gene.
Chromatin remodeling at the Ifng locus may occur by STAT5
recruitment of histone acetyltransferases or chromatin remodel-
ing factors, as has been described in other systems (Bertolino
et al., 2005; Rascle and Lees, 2003; Shuai, 2000; Xu et al.,
2007; Ye et al., 2001). Although we have been unable to detect
constitutive STAT5 binding to the Ifng locus in differentiating
Th1 cells, IL-2 stimulation of T cells 48 hr after initial activation in-
duces robust binding of STAT5 to Ifng regulatory regions, includ-
ing IfngCNS-5.5 and HS-0.3. Interestingly, T-bet is also able toImmunity 28, 763–773, June 2008 ª2008 Elsevier Inc. 769
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cause our data indicate that T-bet binding to the Ifng proximal
promoter is greatly reduced in the absence of STAT5 activation,
we propose that STAT5 functions either before or synergistically
with T-bet to regulate the chromatin remodeling process.
Early studies provided evidence that IL-2 ‘‘primes’’ T cells for
production of both IFN-g and IL-4 (Seder et al., 1994). More re-
cently, IL-2 receptor signaling via STAT5 has been implicated
in the regulation of IL-4 expression and Th2 cell differentiation,
independently of the IL-4/STAT6 pathway (Cote-Sierra et al.,
2004; Zhu et al., 2003). These data, together with our findings,
suggest the intriguing possibility that IL-2, or another gc-depen-
dent cytokine, may be required in the initial stages of both Th1
and Th2 cell differentiation for chromatin remodeling at the Ifng
Figure 6. The Jak3-Dependent Signals Are Required at 24–72 hr of
Stimulation to Induce Histone Acetylation at the Ifng Locus
(A) CD4+ splenocytes were isolated from Jak3+/+ OTII-transgenic mice and
were stimulated under Th1 cell-skewing conditions for 0 hr, 12 hr, 24 hr,
48 hr, and 72 hr. At each time point, ChIP analysis was performed with a rabbit
IgG control antibody (top) or an antibody to acetylated histone H3 (H3 primer
set #3).
(B) CD4+ splenocytes from Jak3+/+ OTII-transgenic mice were stimulated
under Th1 cell-skewing conditions, with vehicle alone or the Jak3 inhbitor
(PS078507 at 625nM) added at the indicated time points after the initiation
of the cultures. All cultures were harvested at day 4, at which time the cells
were restimulated and analyzed for IFN-g production by intracellular cytokine
staining. Cells initially cultured in vehicle alone were restimulated in the
presence of PS078507 at 625 nM (Restim).
(C) CD4+ splenocytes from Jak3+/+ OTII-transgenic mice were stimulated
under Th1 cell-skewing conditions in vehicle alone or with PS078507 (625
nM) added at the indicated times after the initiation of the cultures. At day 4,
ChIP analysis was performed with a rabbit IgG control antibody (top) or an
antibody to acetylated histone H3 (middle) (H3 primer set #3). Freshly isolated
Jak3+/+ OTII-transgenic cells were used for comparison (naive).770 Immunity 28, 763–773, June 2008 ª2008 Elsevier Inc.and Il4 locus, respectively. This requirement would thereby cou-
ple effector CD4+ T cell differentiation with appropriate survival
and growth-promoting signals. In our in vitro system, IL-2 is
the cytokine activating Jak3 and promoting IFN-g production
during Th1 cell differentiation. It remains to be determined
whether STAT5 is inducing chromatin remodeling at the Il4 locus
Figure 7. STAT5 and IL-2 Are Required for Optimal IFN-g Production
during Th1 Cell Differentiation
(A) Purified CD4+ T cells from Jak3+/+ OTII-transgenic mice were stimulated
and cultured in Th1 cell-skewing conditions for 2 days. Cells were rested over-
night and then restimulated with IL-2 (50 ng/ml) for 1 hr. ChIP analysis was
performed with an STAT5a antibody. Rabbit IgG antibody was used as a
negative control. Primers for each of the indicated Ifng regulatory regions
were designed to detect STAT5 binding (STAT5 primer sets #5–10).
(B) Purified CD4SP thymocytes from CD2-Cre transgenic Stat5fl/+ and Stat5fl/fl
mice were stimulated under Th1 cell-skewing conditions. Sodium butyrate
(200 mM)was added at 24 hr after stimulation. At day 4, cells were restimulated
with PMA and Ionomycin. Bar graphs indicate the percentages of IFN-g-pro-
ducing cells. Data are representative of two independent experiments with
similar results.
(C) CD4+ splenocytes from Jak3+/+ mice were cultured under Th1 cell-skewing
conditions for 4 days, in the indicated conditions. Jak3 inhibitor PS078507was
used at 625 nM, IL-2 blocking included anti-IL-2 (10 mg/ml), anti-CD25 (10 mg/
ml), and anti-CD122 (10 mg/ml), and recombinant IL-7 (rIL-7, 10ng/ml) was
added together with IL-2 blocking antibodies. Cells were restimulated with
PMA plus ionomycin for 6 hr. Histograms show IFN-g intracellular staining.
(D) Purified CD4+ splenocytes from Jak3+/+ mice were stimulated with anti-
CD3 plus anti-CD28 for 24 hr, rested for 4 hr, then stimulatedwithmedium (first
lane), IL-2, or IL-7, at 50 ng/ml or 100 ng/ml for 15 min. Cell lysates were
prepared and immunoblotted for STAT5p and total STAT5.
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strate that optimal effector CD4+ T cell differentiation depends
on an additional cytokine signal that is not lineage specific




OTII-transgenic (Barnden et al., 1998) and Bcl2-transgenic (Strasser et al.,
1994) mice were purchased from Jackson laboratory (Bar Harbor, ME).
Jak3/ mice (Thomis et al., 1995) were backcrossed to C57BL/6 for ten gen-
erations. Stat5ab double-deficient mice (Cui et al., 2004) and CD2-cre trans-
genic mice (de Boer et al., 2003) were generously provided by Dr. Joonsoo
Kangwith the permission of Dr. Lothar Hennighausen and Dr. Dmitris Kioussis,
respectively. Mice were maintained at the University of Massachusetts Medi-
cal School specific pathogen-free animal facility after review and approval by
the institutional animal care and use committee.
Cell Isolation, Culture, and In Vitro T Cell Differentiation
CD4 SP thymocytes were sorted on a Mo-Flo sorter (Cytomation, Fort Collins,
CO) to a purity of more than 98%. CD4+ splenocytes were purified (Miltenyi,
Auburn, CA) to a purity of more than 94%. Cells were stimulated with plate-
bound anti-CD3 (1 mg/ml) plus anti-CD28 (4 mg/ml) (eBioscience, San Diego,
CA). Th1 and Th2 cell differentiation conditions included rIL-12 (5ng/ml)
(R&D, Minneapolis, MN) and anti-IL-4 (5 mg/ml) (BD PharMingen), or rIL-4
(20ng/ml) (R&D) and anti-IFN-g (5 mg/ml) (BD PharMingen), respectively. For
nonskewing conditions, no exogenous cytokines or antibodies were added.
For all culture conditions, no exogenous IL-2 was added. IL-2 blocking was
performed by addition of anti-IL-2 plus anti-CD25 plus anti-CD122 (BD Phar-
Mingen), each at 10 mg/ml. Recombinant IL-7 (rIL-7, eBioscience) was used at
10 ng/ml for cell culture and at 50 and 100 ng/ml for STAT5 phosphorylation
assays.
Intracellular Cytokine Staining
One million T cells cultured under nonskewing or Th1 cell-skewing conditions
were restimulated with Phorbol 12-myristate 13-acetate (PMA) (5 ng/ml) plus
ionomycin (375 ng/ml) for 5 hr in a 96-well plate. Golgi Plug was added for
the last 4 hr, and intracellular staining was performed according to the Cyto-
fix/Cytoperm kit protocol (BD PharMingen).
Cytokine ELISA
Three hundred thousand T cells cultured under Th1 cell- or Th2 cell-polarizing
conditions were restimulated with PMA (5 ng/ml) plus ionomycin (375 ng/ml)
for 24 hr. Supernatants were harvested, serially diluted and assayed for IFN-
g, IL-4, IL-5, and IL-10 with cytokine detection kits (BD PharMingen).
Real-Time Quantitative PCR
CD4 SP thymocytes were stimulated for 4 days with anti-CD3 and anti-CD28
under non-, Th1 cell- or Th2 cell-skewing conditions. Total RNAwas extracted,
complementary DNA (cDNA) was generated, and mRNA levels were analyzed
by real-time quantitative PCR as previously described (Miller and Berg, 2002).
18srRNA were used as internal control. The following primers were used: Ifng
sense, 50-CCTGCAGAGCCAGATTATCTC-30, anti-sense, 50-CCTTTTTCGCC
TTGCTGTTGC-30; T-bet sense, 50-TTCCCATTCCTGTCCTTCACC-30, anti-
sense, 50-TGCCTTCTGCCTTTCCACAC-30; 18srRNA sense, 50-TGGTGGAG
GGATTTGTCTGG-30, anti-sense, 50-TCAATCTCGGGTGGCTGAAC-30; IL-
12Rb2 sense, 50-CCCAAGGAAATGAAAGGGAAT-30, anti-sense, 50-TAGCGA
TGCAAATGCTTGATATC-30; Ets-1 sense, 50-GCGCTACGTATACCGCTTTG-
30, anti-sense, 50-CAACCAACAGGGTTGCTCTT-30; andHlx sense, 50-GGGAC
AGTTCTTCGCATCTC-30, anti-sense, 50-CTGTGGCATGGTGTCCTTAG-30.
Immunoblot
Cells lysates were immunoblotted with antibodies to T-bet (Santa Cruz
Biotechnology, Santa Cruz, CA), b-actin (BD PharMingen), phospho-Stat1
(Tyr701) (Cell Signaling Technology, Danvers, MA), total Stat1 (Cell Signaling
Technology), phospho-Stat4 (Y693) (Invitrogen, Carlsbad, CA), total Stat4(Santa Cruz Biotechnology) and phospho-Stat5 (Cell Signaling Technology)
antibodies.
Chromatin Immunoprecipitation
ChIP assays were performed on 1.5 3 106 cells with the ChIP Assay Kit (Up-
state Cell signaling Solutions, Charlottesville, VA). The antibodies used were
anti-T-bet (H-210, Santa Cruz), anti-acetylated histone H3 (Upstate), and
anti-Stat5a (R&D). PCR was performed with 5 ml from a total of 50 ml of the im-
munoprecipitated DNA with various primers. As a control, the PCR was done
directly on input DNA purified from chromatin before immunoprecipitation.
Positions of primers are indicated on amap of themurine Ifng locus (Figure S4).
Primers to detect T-bet binding (Lovett-Racke et al., 2004) were set #1
(Figure S4), 50-CACGTTGACCCTGAGTGAT-30 and 50-GAGGAAACTCTTGGG
CTT C-30. Primers for Stat5a binding were set #6 for IfngCNS-34, 50-AAGCCC
AGAGTGTCAACCAC-30 and 50-GGATCATCTAGCAGCCGTTG-30; set #7 for
IfngCNS-22, 50-CACAGGAAGGAGATGGGAAG-30 and 50-CCCGTTAACCTTC
TGCTCTG-30; set # 8 for IfngCNS-5.5, 50-CCGTGTGGACTTCCATTCTC-30
and 50-GTTACCTCCTCCACCCGTTC-30; set #9 for HS-3.6, 50-ATCAGGAAGG
AACAGGCTTC-30 and 50-CCATCCTTTCGTCTCAGCTC-30; set #5 for HS-0.3,
50-TGCTGTGCTCTGTGGATGAG-30 and 50-GGGCTCTCTGACGATGAGAC-
30; and set #10 for IfngCNS+18, 50-AAGCCAGTTTGTCATCATGC-30 and 50-TT
TGTGCTTTCCTGATTCACC-30. Primers to examine Histone H3 acetylation
were set #3, 50-CGTAATCCCGAGGAGCCTC-30 and 50-CTTTCAATGACTGTG
CCGTGG-30; and set #4, 50-GCTCTGTGGATGAGAAAT-30 and 50-AAGATGGT
GACAGAAGG-30.
Restriction Enzyme Accessibility Assay
Restriction enzyme accessibility experiments with LM-PCR were performed
as previously described (de la Serna et al., 2005). Nuclei were digested with
HinfI. HinfI LM-PCR adaptors were generated by annealing of the two oligos
(50-AATGAATTCAGATC-30 and 50-GCGGTGACCCGGGAGATCTGAATTC-30)
at 95C for 5 min followed by cooling to 25C. The primers for LM-PCR (Fig-
ure S4, primer set #2) were as follows: 50-GGATATTACCACCAAAACTACGCA
G-30 (on Ifng promoter) and 50-GGTGACCCGGGAGATCTGAATTCATTCG-30
(on LM-PCR adaptor). Input DNA was monitored by amplification of the Ifng
promoter in a region that cannot be digested by HinfI, with the following
primers: 50-GTTGACCGTGGTTGATGTTG-30 and 50-TTGTACCTTGGACCTAT
ACTATGC-30.
Statistical Analysis
Statistical analysis was performed with the two-tailed paired student’s t test.
SUPPLEMENTAL DATA
Additional Experimental Procedures and four figures are available at http://
www.immunity.com/cgi/content/full/28/6/763/DC1/.
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